Module 9 Quiz

A  All cell types

B  Human cells

C  Bacterial cells

D  Fungal cells

A  Number of genes

B  Presence of double-stranded DNA

C  Number of chromosomes

D  Structure of chromosomes

A  binding of the primers to the single-stranded DNA.

B  unwinding and separating the double-stranded DNA.

C  making a cDNA from an mRNA strand.

D  adding nucleotides to primed sites of the DNA strands.

A  Addition of a deoxyribonucleotide

B  Addition of a ribonucleotide

C  Deletion of a deoxyribonucleotide

D  Addition of a dideoxynucleotide

A  Oligoligated control

B  Blank control

C  Positive control

D  dTTP control

A  Restriction enzyme

B  Transcriptase

C  Lysozyme

D  Polymerase

A  polymeric molecule composed of nucleic acids.

B  sequence of nucleotides that codes for a protein.

C  phosphate group, a ribose sugar, and nitrogen.

D  sequence of three nucleotides.

A  Methyl group

B  Hydrogen

C  Hydroxyl group

D  Phosphate group

A  hormones.

B  lysosomes.

C  histones.

D  nucleotides.

A  20%

B  60%

C  30%

D  40%

A  toxin effect.

B  toxidrome.

C  pattern constellation.

D  metabolic pattern.

A  immunoassay.

B  spectrophotometry.

C  flame ionization gas chromatography (GC).

D  HPLC.

A  The hepatic necrosis is caused by depletion of a substance in the liver and eventual accumulation of the oxidized metabolite.

B  The coma produced is caused by an immediate decrease in sensitivity to CO2 concentration through depression of respiratory centers in the brain.

C  The myocardial infarction is caused by the effect on respiratory centers in the brain and eventual lack of stimulation of the heart.

D  The metabolic acidosis produced is caused by increased formation of formic acid by the liver during metabolism.

A  [Cl−] + [Na+ +  [HCO3-]

B  [Na+] + [Cl− +  [HCO3-]

C  [HCO3-]  − [Na+ + Cl−].

D  [Na+] − [Cl− +  [HCO3-]

A  a more sensitive and specific immunoassay procedure.

B  GC-MS.

C  electrophoresis.

D  a spot test.

A  Immediately before a dose of the drug is given.

B  At 8 AM, when liver metabolism is highest.

C  There is no specific time that is the best for blood collection.

D  Immediately after a dose of the drug is given.

A  To determine drug concentrations in a pathophysiological state

B  To monitor drugs with a broad therapeutic range

C  To check patient compliance

D  To monitor significant drug-drug interactions

A  Using a different route of administration than is typically used for that drug

B  Increased drug metabolism caused by central nervous system disease

C  Decreased renal elimination leading to increased free drug concentration

D  Using a single drug as opposed to multiple drugs for treatment

A  Albumin, Lipoprotein, and α1-Glycoprotein

B  α1-Glycoprotein

C  Albumin

D  Lipoprotein

A  subtherapeutic range.

B  volume of distribution.

C  dosing curve.

D  half-life.